Anti-inflammation effects of sophora flavescens nanoparticles

Inflammation

Volumn 35, Issue 4, 2012, Pages 1262-1268

  Han, Chun Chao ^a   Wang, Yingzi ^b  

^a SHANDONG UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Inflammation; Inflammatory cells; Inflammatory mediators; Nanoparticles; Sophora flavescens

Indexed keywords

NANOPARTICLE; SODIUM CHLORIDE; SOPHORA FLAVESCENS EXTRACT; SOPHORA FLAVESCENS NANOPARTICLE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; DRUG ABSORPTION; DRUG DETERMINATION; DRUG EFFICACY; DRUG SOLUBILITY; HYDROLYSIS; MALE; NONHUMAN; PH; PLANT ROOT; RAT; SOPHORA FLAVESCENS; ULTRASOUND; UVEITIS;

ANIMALS; ANTI-ASTHMATIC AGENTS; ANTI-INFLAMMATORY AGENTS; CYCLOOXYGENASE 2; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; LIPOPOLYSACCHARIDES; MALE; NANOPARTICLES; NITRIC OXIDE SYNTHASE TYPE II; PLANT PREPARATIONS; PLANT ROOTS; RATS; RATS, WISTAR; SOPHORA; UVEITIS;

SOPHORA FLAVESCENS;

EID: 84866728976     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-012-9437-6     Document Type: Article

References (32)

1. Yagi, A., M. Fukunaga, N. Okuzako, I. Mifuchi, and F. Kawamoto. 1989. Antifungal substances from Sophora flavescens. Shoyakugaku Zasshi 43: 343-347.
2. Kuroyanagi, M., T. Arakawa, Y. Hirayama, and T. Hayashi. 1999. Antibacterial and antiandrogen flavonoids from Sophora flavescens. Journal of Natural Products 62: 1595-1599.
3. Kim, D.W., Y.S. Chi, K.H. Son, H.W. Chang, J.S. Kim, S.S. Kang, and H.P. Kim. 2002. Effects of sophoraflavanone G, a prenylated flavonoid from Sophora flavescenes, on cyclooxygenase-2 and in vitro inflammatory response. Archives of Pharmacal Research 25: 329-335.
4. Hwang, J.S., S.A. Lee, S.S. Hong, K.S. Lee, M.K. Lee, B.Y. Hwang, and J.S. Ro. 2005. Monoamine oxidase inhibitory components from the roots of Sophora flavescens. Archives of Pharmacal Research 28: 190-194.
5. Jung, H.J., S.S. Kang, S.K. Hyun, and J.S. Choi. 2005. In vitro free radical and ONOO-scavengers from Sophora flavescens. Archives of Pharmacal Research 28: 534-540.
6. Tang, W., and G. Eisenbrand. 1992. Chinese drugs of plant origin, 931-994. Heidelberg: Springer.
7. Mizoe, T., T. Ozeki, and H. Okada. 2007. Preparation of drug nanoparticle-containing microparticles using a4-fluid nozzle spray drier for oral, pulmonary and injection dosage forms. Journal of Controlled Release 122: 10-15.
8. Texter, J. 2001. Precipitation and condensation of organic particles. Journal of Dispersion Science and Technology 22: 499-527.
9. Horn, D., and J. Rieger. 2001. Organic nanoparticles in the aqueous phase-Theory, experiment and use. Angewandte Chemie (International Ed. in English) 40: 4330-4361.
10. Bilgili, E., R. Hamey, and B. Scarlett. 2004. Production of pigment nanoparticles using a wet stirred media mill with polymeric media. China Part 2:93-100.
11. Bilgili, E., R. Hamey, and B. Scarlett. 2006. Nano-milling of pigment agglomerates using a wet stirred media mill: Elucidation of the kinetics and breakage mechanisms. Chemical Engineering Science 61: 149-157.
12. Thiruvengadathan, R., Y. Levi-Kalisman, O. Regev, Ultrason. Sonochem. 2007. Synergetic effect of ultrasound and sodium dodecyl sulphate in the formation of CdS nanostructures in aqueous solution 14:398-404.
13. Entezari, M.H., N. Ghows, and M. Chamsaz. 2005. Combination of ultrasound and discarded tire rubber: Removal of Cr (III) from aqueous solution. Journal of Physical Chemistry A 109: 4638-4642.
14. Entezari, M.H., N. Ghows, and M. Chamsaz. 2006. Ultrasound facilitates and improves removal of Cd (II) from aqueous solution by the discarded tire rubber. Journal of Hazardous Materials B 131: 84-89.
15. Mason, T.J. 1990. Sonochemistry: The uses of ultrasound in chemistry, The Royal Society of Chemistry.
16. Price, G.J. 1992. Current trends in sonochemistry, The Royal Society of Chemistry.
17. Yu, J.C., J. Yu, W. Ho, and L. Zhang. 2001. Preparation of highly photocatalytic active nano-sized TiO2 particles via ultrasonic irradiation. Chemical Communications 7: 1942-1943.
18. Pérez, J., J. Muñoz-Dorado, T. De-la-Rubia, and J. Martínez. 2002. Biodegradation and biological treatments of cellulose, hemicellulose and lignin: An overview. International Microbiology 5: 53-63.
19. Moure, A., P. Gullon, H. Dominguez, and J.C. Parajo. 2006. Advances in the manufacture, purification and applications of xylooligosaccharides as food additives and nutraceuticals. Process Biochemistry 41: 1913-1923.
20. Merisko-Liversidge, E., P. Sarpotdar, J. Bruno, S. Hajj, L. Wei, N. Peltier, et al. 1996. Formulation and antitumor activity evaluation of nanocrystalline suspensions of poorly soluble anticancer drugs. Pharmaceutical Research 13: 272-278.
21. Merisko-Liversidge, E., G.G. Liversidge, and E.R. Cooper. 2003. Nanosizing: A formulation approach for poorly-water-soluble compounds. European Journal of Pharmaceutical Sciences 18: 113-120.
22. VanEerdenbrughB, Froyen.L., Blaton.N. MartensJA, P. Augustijns, M. Brewster, et al. 2007. Characterization of physico-chemical properties and pharmaceutical performance of sucrose co-freezedried solid nanoparticulate powders of the anti-HIV agent loviride prepared by media milling. International Journal of Pharmaceutics 338: 198-206.
23. Van Eerdenbrugh, B., L. Froyen, J. Van Humbeeck, J.A. Martens, P. Augustijns, and G. Van den Mooter. 2008. Drying of crystalline drug nanosuspensions-The importance of surface hydrophobicity on dissolution behavior upon redispersion. European Journal of Pharmaceutical Sciences 35: 127-135.
24. Van Eerdenbrugh, B., L. Froyen, J. Van Humbeeck, J.A. Martens, P. Augustijns, and G. Van Den Mooter. 2008. Alternative matrix formers for nanosuspension solidification: dissolution perfor-mance and x-ray microanalysis as an evaluation tool for powder dispersion. European Journal of Pharmaceutical Sciences 35: 344-353.
25. Jacobs, C., and H. Müller. 2002. Production and characterization of a budesonide nanosuspension for pulmonary administration. Pharmaceutical Research 19: 189-194.
26. Hecq, J., M. Deleers, D. Fanara, H. Vranckx, P. Boulanger, S. Le Lamer, et al. 2006. Preparation and in vitro/in vivo evaluation of nano-sized crystals for dissolution rate enhancement of ucb-35440-3, a highly dosed poorly water-soluble weak base. European Journal of Pharmaceutics and Biopharmaceutics 64: 360-368.
27. Riddick, T. 1968. Control of colloid stability through zeta potential: With a closing chapter on its relationship to cardiovascular disease, Zeta-Meter, Inc.
28. Grant, D.J.W., and H.G. Brittain. 1995. Solubility of pharmaceutical solids. In: Brittain HG, editor. Physical characterization of pharmaceutical solids, drugs and the pharmaceutical sciences. New York: Marcel Dekker.70: 321-86.
29. McNeil, S.E. 2005. Nanotechnology for the biologist. Jounal of Leukocyte Biology 78: 585-592.
30. Kesisoglou, F., S. Panmai, and Y. Wu. 2007. Nanosizing-oral formulation development and biopharmaceutical evaluation. Advanced Drug Delivery Reviews 59: 631-644.
31. Duchêne, D., and G. Ponchel. 1997. Bioadhesion of solid oral dosage forms, why and how? European Journal of Pharmaceutics and Biopharmaceutics 44: 15-23.
32. Vasir, J.K., K. Tambwekar, and S. Garg. 2003. Bioadhesive microspheres as a controlled drug delivery system. International Journal of Pharmaceutics 255: 13-32.